Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone vs dexmedetomidine vs magnesium sulfate in caudal neuroplasty for chronic low back pain
IRCT20111102007984N32Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of triamcinolone, dexmedetomidine and magnesium sulfate in chronic low back pain (CLBP) (4 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Visual analogue scale at 6 months and Oswestry Disability Index at 6 months. Started Mar 2020; status: completed.
02
Drugs
triamcinolonedexmedetomidinemagnesium sulfate
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on IRCT20111102007984N32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111102007984N32.